rs147750704
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 3P and 7B. PM1PP2BP4_ModerateBS1_SupportingBS2
The NM_000891.3(KCNJ2):c.277G>A(p.Val93Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,614,192 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000891.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251482Hom.: 1 AF XY: 0.000169 AC XY: 23AN XY: 135918
GnomAD4 exome AF: 0.000118 AC: 172AN: 1461894Hom.: 1 Cov.: 32 AF XY: 0.000128 AC XY: 93AN XY: 727248
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74468
ClinVar
Submissions by phenotype
Atrial fibrillation, familial, 9 Pathogenic:2
We observed p.V93I variant in a 15-y.o. female proband with borderline QTc prolongation. This variant was shown to have in vitro effect (PS3 criteria); several in silico tools predict the variant to be pathogenic (PP3 criteria); additionally, it was previously shown for the variant to have a gain-of-function effect of this variant on Kir2.1 channel. Based on the evidence, we consider the p.V93I variant to be likely pathogenic. -
- -
not provided Uncertain:1Benign:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25637381, 23631430, 15922306, 19041665, 29247119, 25410959) -
KCNJ2: BS1 -
Atrial fibrillation Uncertain:1Other:1
This variant has been reported as associated with Atrial fibrillation in the following publications (PMID:15922306;PMID:19041665). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
- -
Andersen Tawil syndrome;C1865018:Short QT syndrome type 3 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 93 of the KCNJ2 protein (p.Val93Ile). This variant is present in population databases (rs147750704, gnomAD 0.03%). This missense change has been observed in individual(s) with atrial fibrillation and/or long QT syndrome (PMID: 15922306, 23631430, 25410959, 35456365). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30121). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNJ2 protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on KCNJ2 function (PMID: 15922306, 19041665, 19111761). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Long QT syndrome Uncertain:1
Criteria: PM1, BP4 -
Andersen Tawil syndrome Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Short QT syndrome type 3 Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at